A detailed history of Samlyn Capital, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Samlyn Capital, LLC holds 4,906,703 shares of PFE stock, worth $135 Million. This represents 2.44% of its overall portfolio holdings.

Number of Shares
4,906,703
Previous 3,460,121 41.81%
Holding current value
$135 Million
Previous $96 Million 42.98%
% of portfolio
2.44%
Previous 1.7%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$25.26 - $29.6 $36.5 Million - $42.8 Million
1,446,582 Added 41.81%
4,906,703 $137 Million
Q1 2024

May 15, 2024

BUY
$25.89 - $29.73 $52.1 Million - $59.9 Million
2,013,275 Added 139.15%
3,460,121 $96 Million
Q4 2023

Feb 14, 2024

BUY
$26.13 - $33.94 $37.8 Million - $49.1 Million
1,446,846 New
1,446,846 $41.7 Million
Q2 2020

Aug 14, 2020

SELL
$30.12 - $36.54 $23.5 Million - $28.5 Million
-780,961 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$27.03 - $38.62 $21.1 Million - $30.2 Million
780,961 New
780,961 $25.5 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Samlyn Capital, LLC Portfolio

Follow Samlyn Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Samlyn Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Samlyn Capital, LLC with notifications on news.